Key features of Stifel Discover include: Seamless Access - Easily accessible from the Wealth Tracker home screen, Stifel ...

Stifel analysts reaffirmed their Buy rating on Generac Holdings (NYSE:GNRC) with a consistent price target of $210.00. Currently trading at $145.07 with a market capitalization of $8.63 billion, ...

Stifel analysts maintained their Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA), currently trading at $5.24, with a steady price target of $21.00. According to InvestingPro data, analyst targets ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Stifel Financial Corp. (NYSE: SF) will release its fourth quarter and full year 2024 financial results before the market opens on Wednesday, January 29, 2025. The company will host a conference call ...

In a report released today, Benjamin Burnett from Stifel Nicolaus maintained a Buy rating on Iovance Biotherapeutics (IOVA – Research Report), ...

Good day and welcome to the Stifel Financial fourth quarter financial ... as well as the growth in commercial deposits enabled us to maintain deposit levels and avoid the impact of cash [sorting ...

ST. LOUIS, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported net revenues of $1.36 billion for the three months ended December 31, 2024, compared with $1.15 ...

--(BUSINESS WIRE)--Sintavia, LLC, the world’s leading all-digital aerospace component manufacturer, announced today that it has received a $10 million subordinated debt investment from the ...